All Stories

  1. Analysis of indirect treatment comparisons in national health technology assessment assessments and requirements for industry submissions
  2. Medical devices: have health technology assessment agencies started to focus more on them?
  3. Acceptance of Surrogate Endpoints by HTA Agencies in Europe
  4. The Importance of Patient Reported Outcomes in Reimbursement of Orphan Products in Europe